Multifluid Metabolomics Identifies Novel Biomarkers for Irritable Bowel Syndrome

Multifluid Metabolomics Identifies Novel Biomarkers for Irritable Bowel Syndrome

<b>Background/Objectives</b>: Irritable bowel syndrome (IBS) is a complex disorder affecting 10% of the global population, but the underlying mechanisms remain poorly understood. By integrating multifluid metabolomics, we aimed to identify metabolite markers of IBS in a large population-...

Full description

Bibliographic Details
Main Authors: Daniel Kirk, Panayiotis Louca, Ilias Attaye, Xinyuan Zhang, Kari E. Wong, Gregory A. Michelotti, Mario Falchi, Ana M. Valdes, Frances M. K. Williams, Cristina Menni
Format: Article
Language:English
Published: MDPI AG 2025-02-01
Series:Metabolites
Subjects:
irritable bowel syndrome
serum
stool
urine metabolomics
Online Access:https://www.mdpi.com/2218-1989/15/2/121

Internet

https://www.mdpi.com/2218-1989/15/2/121

Similar Items